Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Key Studies in Genitourinary Cancers: Independent Conference Coverage of the 2020 ASCO Virtual Scientific Meeting

Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS
Released: September 1, 2020
Back Next

Introduction

In this module, Daniel P. Petrylak, MD, and Elizabeth R. Plimack, MD, MS, discuss the most clinically important study results presented at the 2020 American Society of Clinical Oncology virtual scientific meeting across multiple genitourinary cancers, including renal cell carcinoma (RCC), urothelial carcinoma (UC), and prostate cancer.

Please note that the slide thumbnails in this activity link to individual PowerPoint slidesets, each focused on the specific study or topic of interest. These slidesets may be downloaded by clicking any of the thumbnails within the activity.

Clinical Care Options plans to measure the educational impact of this activity. A few questions will be asked twice: once before the discussion that informs the best choice, and then again after that specific discussion. Your responses will be aggregated for analysis, and your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following questions.

Back Next
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca
Bayer HealthCare Pharmaceuticals Inc.
Bristol-Myers Squibb
Exelixis
Pfizer, Inc. and EMD Serono

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue